Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders

被引:0
|
作者
Ashley N. Brandebura
Adrien Paumier
Tarik S. Onur
Nicola J. Allen
机构
[1] Salk Institute for Biological Studies,Molecular Neurobiology Laboratory
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
There is increasing appreciation that non-neuronal cells contribute to the initiation, progression and pathology of diverse neurodegenerative disorders. This Review focuses on the role of astrocytes in disorders including Alzheimer disease, Parkinson disease, Huntington disease and amyotrophic lateral sclerosis. The important roles astrocytes have in supporting neuronal function in the healthy brain are considered, along with studies that have demonstrated how the physiological properties of astrocytes are altered in neurodegenerative disorders and may explain their contribution to neurodegeneration. Further, the question of whether in neurodegenerative disorders with specific genetic mutations these mutations directly impact on astrocyte function, and may suggest a driving role for astrocytes in disease initiation, is discussed. A summary of how astrocyte transcriptomic and proteomic signatures are altered during the progression of neurodegenerative disorders and may relate to functional changes is provided. Given the central role of astrocytes in neurodegenerative disorders, potential strategies to target these cells for future therapeutic avenues are discussed.
引用
收藏
页码:23 / 39
页数:16
相关论文
共 50 条
  • [41] Urate as a Marker of Risk and Progression of Neurodegenerative Disease
    Paganoni, Sabrina
    Schwarzschild, Michael A.
    [J]. NEUROTHERAPEUTICS, 2017, 14 (01) : 148 - 153
  • [42] The contribution of GABAergic dysfunction to neurodevelopmental disorders
    Ramamoorthi, Kartik
    Lin, Yingxi
    [J]. TRENDS IN MOLECULAR MEDICINE, 2011, 17 (08) : 452 - 462
  • [43] Urate as a Marker of Risk and Progression of Neurodegenerative Disease
    Sabrina Paganoni
    Michael A. Schwarzschild
    [J]. Neurotherapeutics, 2017, 14 : 148 - 153
  • [44] Astrocyte dysfunction and neurovascular impairment in neurological disorders: Correlation or causation?
    McConnell, Heather L.
    Li, Zhenzhou
    Woltjer, Randall L.
    Mishra, Anusha
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2019, 128 : 70 - 84
  • [45] Aluminum toxicity and astrocyte dysfunction: A metabolic link to neurological disorders
    Lemire, Joseph
    Appanna, Vasu D.
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2011, 105 (11) : 1513 - 1517
  • [46] Contribution of Energy Dysfunction to Impaired Protein Translation in Neurodegenerative Diseases
    Liu, Yu-Ju
    Chern, Yijuang
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [47] Microglial dysfunction and genetic risk for neurodegenerative disease
    Debra S.MacDonald
    Jay Penney
    [J]. Neural Regeneration Research, 2025, 20 (05) : 1401 - 1402
  • [48] The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer’s disease
    Yu-Wen Cheng
    Ming-Jang Chiu
    Ya-Fang Chen
    Ting-Wen Cheng
    Ya-Mei Lai
    Ta-Fu Chen
    [J]. Alzheimer's Research & Therapy, 12
  • [49] The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer's disease
    Cheng, Yu-Wen
    Chiu, Ming-Jang
    Chen, Ya-Fang
    Cheng, Ting-Wen
    Lai, Ya-Mei
    Chen, Ta-Fu
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [50] DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders
    Marinescu, Razvan, V
    Eshaghi, Arman
    Lorenzi, Marco
    Young, Alexandra L.
    Oxtoby, Neil P.
    Garbarino, Sara
    Crutch, Sebastian J.
    Alexander, Daniel C.
    [J]. NEUROIMAGE, 2019, 192 : 166 - 177